RFL实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 03:06):

Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel...

Stats
今日成交量	15 210.00
平均成交量	23 488.00
市值	40.57M
EPS	$0 ( 2024-03-12 )
下一个收益日期	( $0 ) 2024-06-11
Last Dividend	$0.0200 ( 2009-12-18 )
Next Dividend	$0 ( N/A )
P/E	17.05
ATR14	$0.0220 (1.29%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-04	Jonas Howard S	Buy	348 259	Class B Common Stock, par value $.01 per share
2024-04-04	Jonas Howard S	Sell	348 259	Class B Common Stock, par value $.01 per share
2024-03-21	Conkling William	Buy	15 473	Class B Common Stock, par value $.01 per share
2024-03-21	Polinsky David	Sell	2 300	Class B Common Stock, par value $.01 per share
2024-01-30	Jonas Howard S	Buy	348 259	Class B Common Stock, par value $.01 per share

INSIDER POWER
52.49
Last 99 transactions
Buy: 18 593 840 \| Sell: 14 829 947

Rafael Holdings Inc 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Rafael Holdings Inc 财务报表

Annual	2023
营收:	$279 000
毛利润:	$201 000 (72.04 %)
EPS:	$-0.0806

FY	2023
营收:	$279 000
毛利润:	$201 000 (72.04 %)
EPS:	$-0.0806

FY	2022
营收:	$410 000
毛利润:	$338 000 (82.44 %)
EPS:	$-6.31

FY	2021
营收:	$3.97M
毛利润:	$0.00 (0.00 %)
EPS:	$-1.490

Financial Reports:

No articles found.

Rafael Holdings Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Rafael Holdings Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.90 - low (62.71%) | Divividend Growth Potential Score: 0.471 - No dividend growth expected in the near future

Information

First Dividend	$0.0200	2009-06-19
Last Dividend	$0.0200	2009-12-18
Next Dividend	$0	N/A
Payout Date	2009-12-31
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	$0.0400	--
Avg. Dividend % Per Year	0.00%	--
Score	1.83	--
Div. Sustainability Score	4.90
Div.Growth Potential Score	0.471
Div. Directional Score	2.69	--

Next Divdend (Est)
(2024-10-14)

$0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

1.83

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
NCZ	Dividend Royal	2024-02-09	Monthly	22	7.79%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
SJT	Dividend Royal	2023-11-29	Monthly	39	12.52%	8.50
GOF	Dividend Royal	2023-11-14	Monthly	18	8.03%	8.50
SRV	Dividend Royal	2023-12-04	Monthly	18	7.53%	8.50
VGI	Dividend Royal	2024-02-09	Monthly	13	7.36%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	7.77	1.500	10.00	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0201	1.200	9.33	10.00	[0 - 0.3]
returnOnEquityTTM	0.0213	1.500	-0.875	-1.312	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	23.01	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	22.86	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	2.19	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0160	-1.500	9.73	-10.00	[0 - 0.6]
interestCoverageTTM	-7.98	1.000	-4.07	-4.07	[3 - 30]
operatingCashFlowPerShareTTM	-0.314	2.00	-0.105	-0.209	[0 - 30]
freeCashFlowPerShareTTM	1.775	2.00	9.11	10.00	[0 - 20]
debtEquityRatioTTM	0.0162	-1.500	9.94	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.665	1.000	2.24	2.24	[0.2 - 0.8]
operatingProfitMarginTTM	-40.96	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-4.37	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0.00259	0.800	-3.32	-2.65	[0.5 - 2]
Total Score				4.90

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	18.85	1.000	8.20	0	[1 - 100]
returnOnEquityTTM	0.0213	2.50	-0.562	-1.312	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.775	2.00	9.41	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.314	2.00	-0.105	-0.209	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.313	1.500	-1.246	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-27.00	1.000	-10.00	0	[0.1 - 0.5]
Total Score				0.471

Rafael Holdings Inc

Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company's lead drug candidate is CPI-613 (devimistat), which is being evaluated in various clinical studies, including two Phase III registrational clinical trials for the treatment of metastatic pancreatic cancer and r/r acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.